期刊文献+

经皮下肾膀胱分流手术的临床应用 被引量:9

Clinical application of subcutaneous nephrovesical bypass system
下载PDF
导出
摘要 目的:探讨经皮下肾膀胱分流手术在治疗输尿管梗阻患者中的应用价值。方法:晚期盆、腹腔恶性肿瘤患者36例,男18例,女18例,平均年龄60岁(37~82岁),其中双侧输尿管梗阻9例,右侧输尿管梗阻19例,左侧输尿管梗阻8例。B超检查显示患侧的平均肾盂积水宽度3.2cm(1.8~5.2cm),血清肌酐水平261μmol/L(73~760μmol/L),患肾的肾小球滤过率为22mL/min(19~26mL/min),逆行造影显示患侧输尿管完全梗阻。使用肾膀胱分流套件,共行经皮下肾膀胱分流手术45次。术后复查B超、立位腹平片(KUB)、血清肌酐水平以及肾小球滤过率。结果:36例患者均手术顺利,成功放置肾膀胱分流导管。术后72h复查B超,平均肾积水宽度0.6cm(0~1.8cm),导管位置良好,血清肌酐水平105μmol/L(72~173μmol/L),肾小球滤过率33mL/min(25~40mL/min)。患者术后生活质量评价均较术前有所改善。平均随访时间305天(67~481天)。结论:经皮下肾膀胱分流手术操作简单、微创,可有效保护因输尿管梗阻而损害的肾脏功能,明显减少肾造瘘的并发症,提高了患者的生活质量。 Objective:To evaluated the subcutaneous nephrovesical bypass carried out in patients with ureter obstruction and improve the quality of life of patients with palliative definitive percutaneous nephrostomy.Methods:A total of 36 patients with advanced cancer receiving 45 subcutaneous nephrovesical bypass tubes were included in the study.Uronephrosis ranged from 1.8-5.2 cm,serum creatinine 73-760 μmol/L,and glomerular filtration rate(GFR) 19-26 mL/min.The obstruction was proved to be complete by retrograde pyelography.The nephrovesical stents were inserted utilizing percutaneous access to both of the kidney and bladder,and a subcutaneous tunnel was created between the two sites.B-ultrasound,KUB(kidneys,ureters,and bladder),serum creatinine test and GFR were carried out 72 hours after operation.Results:Urinary diversion operations were successful in the 36 patients,uronephrosis ranged from 0-1.8 cm,all stents were in position,serum creatinine 72-173 μmol/L,GFR 25-40 mL/min after the operation,and the bypass functioned well in 45 stents for 67 to 481 days of the follow-up.Conclusion:Subcutaneous nephrovesical bypass can protect renal function of patients suffering from ureteral obstruction by simple and minimum invasive operation;it can also reduce complications caused by percutaneous nephrostomy and improve the patient's life quality.
作者 李钧 王晓峰
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2010年第4期473-475,共3页 Journal of Peking University:Health Sciences
关键词 肾造口术 经皮 输尿管梗阻 肾盂积水 Nephrostomy percutaneous Ureteral obstruction Hydronephrosis
  • 相关文献

参考文献9

  • 1Hausegger KA,Portngaller HR.Percutaneous nephrostomy and antegrade ureteral stenting:technique indications complications[J].Eur Radiol,2006,16(9):2016-2030.
  • 2Jurczok A,Loertzer H,Wagner S,et al.Subcutaneous nephrovesical and nephrocutaneous bypass[J].Gynecol Ohstet Invest,2005,59(3):144-148.
  • 3Nakada SY,Gerber A J,Wolf JS Jr,et al.Subcutaneous urinary diversion utilizing a nephrovesical stent:a superior alternative to longterm external drainage?[J].Urology,1995,45(3):538-541.
  • 4Minhas S,Irving HC,Lloyd SN,et al.Extra-anatomic stems in ureteric obstruction:experience and complications[J].BJU Int,1999,84(7):762-764.
  • 5Chung SY,Stein RJ,Landsittel D,et al.15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents[J].J Urol,2004,172(2):592-595.
  • 6Nissenkom I,Gdor Y.Nephrovesical subcutaneous stent:an alternative to permanent nephrostomy[J].J Urol,2000,163(2):528-530.
  • 7Png JC,Chapple CR.Principles of ureteric reconstruction[J].Curr Opin Urol,2000,10(3):207-212.
  • 8Desgrandchamps F,Leroux S,Ravery V,et al.Subcutaneous pyelovesical bypass as replacement for standard percutaneous nephrostomy for palliative urinary diversion:prospective evaluation of patient's quality of life[J].J Endourol,2007,21 (2):173-176.
  • 9Aaronson NK,Ahmedzai S,Bergman B,et al.The European Organization for Research and Treatment of Cancer QLQ-C30:a quality-of-life instrument for use in international clinical trials in oncology[J].J Natl Cancer Inst,1993,85(5):365-376.

同被引文献58

  • 1Jurczok A, Loertzer h, Wangner S, et al. Subcutaneous nephrovesical ang nephrocutaneous bypass [J]. Gynecol Obstet, 2005,59 (3) : 144-148.
  • 2Desgrandchamps F, Leroux S, Ravery V, et al. Subcutaneous pyelovesical bypass as replacement for standara percutaneous nephrostomy for palliative urinary diversion: prospective evaluation of patient's quality of life[J] J Endourol, 2007,21 (2) 173-176.
  • 3Jabbour ME, Desgrandchamps F, Angelescu E, et al. Percutaneous implantation of subcutaneous prosthetic ureter, long term outeomne[J]. J Endourol, 2001,15(6) : 611 614.
  • 4Chung SY,Stein RJ,Landsittel D,et al.15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents[J] .J Urol, 2004, 172 (2). 592-595.
  • 5Hausegger KA,Portugaller HE.Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications[J].Eur Eadiol, 2006,16(9):2016-2030.
  • 6Lingam K,Paterson PJ,Lingam MK,et al.Subcutaneous urinary diversion, an aIternatire to percutaneous nephrostomy[J]. J Urol, 1994,152(1): 70-72.
  • 7Desgrandchamps F,Leroux S,Eavery V.Subcutaneous pyelovesical bypass as replacement for standard percutaneous nephrostomy for pslliative urinary diversion=prospective evaluation of patient's quality of life[J].J Endourol,2007,21 (2):173-176.
  • 8温星桥,高新,张勇,蔡育彬,邱剑光,司徒杰,湛海伦,王德娟.盆腔恶性肿瘤术后输尿管下段梗阻的腔镜手术治疗(英文)[J].癌症,2007,26(11):1227-1230. 被引量:6
  • 9Izumi K, Mizokami A, Maeda Y, et al. Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction. J Uro1,2011,185 (2) :556 - 561.
  • 10Song Y, Fei X, Song Y. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies. Int J Gynecol Cancer,2012,22(4) :697 - 702.

引证文献9

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部